Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer

Authors
Category Primary study
Year 1999
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The authors highlighted that the delayed administration of G-CSF was as safe as the early start, and it was associated with cost savings, due to the shorter duration of the drug course.
Epistemonikos ID: dee977711398c89197d1a5f59a8be4c0af6e908e
First added on: Apr 19, 2023